Receiver operating characteristic curves analysis were used to assess the performance of the PIVKA-II, CA 19-9, CA 242 and CEA in discriminating PC from benign pancreatic diseases (Table 2). This evidence concerns the gene CEACAM5 and pachyonychia congenita.